Depiction of Prostate Cancer Treatment Alternatives in Greece
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00733213|
Recruitment Status : Completed
First Posted : August 12, 2008
Last Update Posted : October 14, 2009
A retrospective, registry analysis of the socio-economic and demographic characteristics of patients suffering from locally advanced or metastatic prostate cancer, as well as the depiction of the therapeutic algorithms followed in the Greek clinical practice.
- Target Group: Patients with locally advanced or metastatic prostate cancer.
- The first 10 consecutive patients records that meet the entry criteria.
|Condition or disease|
|Locally Advanced or Metastatic Prostate Cancer.|
|Study Type :||Observational|
|Estimated Enrollment :||310 participants|
|Official Title:||Depiction of Prostate Cancer Treatment Alternatives in Greece|
|Study Start Date :||January 2008|
|Actual Study Completion Date :||March 2009|
- Percentage of patients treated by each treatment alternative. [ Time Frame: Between 2002 - 2008 ]
- To depict sociodemographic characteristics and comorbidities. [ Time Frame: Between 2002 - 2008 ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00733213
|Study Director:||Panagiotis Pontikis, MD||AstraZeneca Greece|